Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer

BACKGROUND: Patients with luminal HER2-negative tumours have a favourable prognosis. However, there is a subpopulation in which poorer outcomes are obtained with endocrine therapy alone. This subpopulation is considered to benefit from chemotherapy. However, the significance of chemotherapy for thos...

Descripción completa

Detalles Bibliográficos
Autores principales: Horimoto, Yoshiya, Arakawa, Atsushi, Tanabe, Masahiko, Sonoue, Hiroshi, Igari, Fumie, Senuma, Koji, Tokuda, Emi, Shimizu, Hideo, Kosaka, Taijiro, Saito, Mitsue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124146/
https://www.ncbi.nlm.nih.gov/pubmed/25073969
http://dx.doi.org/10.1186/1471-2407-14-550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124146/
https://www.ncbi.nlm.nih.gov/pubmed/25073969
http://dx.doi.org/10.1186/1471-2407-14-550

Ejemplares similares